{"id":998196,"date":"2026-08-26T08:36:01","date_gmt":"2026-08-26T12:36:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/"},"modified":"2026-08-26T08:36:01","modified_gmt":"2026-08-26T12:36:01","slug":"niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/","title":{"rendered":"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit"},"content":{"rendered":"<p>        <!--.bwalignl { text-align: left }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignl\"><b>Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit<\/b><\/p>\n<p class=\"bwalignl\">LOS ANGELES&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;esheet=54594900&amp;newsitemid=20260826608934&amp;lan=en-US&amp;anchor=Niagen+Bioscience%2C+Inc.&amp;index=1&amp;md5=3e9d52e50e3df5c742ad1d08eebffd5e\">Niagen Bioscience, Inc.<\/a> (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate in the Nasdaq X LD Micro Inaugural SF Summit on Wednesday, September 9, 2026, in San Francisco, CA.<\/p>\n<p class=\"bwalignl\">Nasdaq is partnering with LD Micro to host 25 curated public companies, each delivering a 15-minute presentation to a room of institutional investors within the Nasdaq San Francisco office. Each presenting company will also participate in dedicated 15-minute breakout sessions immediately following their presentations, allowing interested investors to ask questions and engage directly with management.<\/p>\n<p class=\"bwalignl\">Niagen Bioscience CFO, Ozan Pamir, will present at 11:20 a.m. PT, followed by a 15-minute breakout session with local institutional investors. Mr. Pamir will also be available for one-on-one meetings with institutional investors at the conference.<\/p>\n<p class=\"bwalignl\">If you would like to schedule a one-on-one meeting with the Niagen Bioscience management team during the conference, please contact your respective conference representative or email <a rel=\"nofollow\" href=\"mailto:Niagen@KCSA.com\">Niagen@KCSA.com<\/a>.<\/p>\n<p class=\"bwalignl\">For additional information on Niagen Bioscience, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.niagenbioscience.com&amp;esheet=54594900&amp;newsitemid=20260826608934&amp;lan=en-US&amp;anchor=www.niagenbioscience.com&amp;index=2&amp;md5=49869aa0c68414c8c31f62dc7ec55c3f\">www.niagenbioscience.com<\/a>.<\/p>\n<p class=\"bwalignl\"><b>About Niagen Bioscience<\/b><\/p>\n<p class=\"bwalignl\"><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;esheet=54594900&amp;newsitemid=20260826608934&amp;lan=en-US&amp;anchor=Niagen+Bioscience%2C+Inc.&amp;index=3&amp;md5=887bccb6903bf9393352a139a6a816fa\">Niagen Bioscience, Inc.<\/a> (NASDAQ: NAGE) is the global authority in healthy aging and NAD+ (nicotinamide adenine dinucleotide) science. As a trusted pioneer of NAD+ discoveries, Niagen Bioscience<sup><b>\u2122<\/b><\/sup> is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions.<\/p>\n<p class=\"bwalignl\">The Niagen Bioscience team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality.<\/p>\n<p class=\"bwalignl\">Distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and collaborations with leading research institutions worldwide, Niagen Bioscience sets the gold standard for research, quality, and innovation. There\u2019s a better way to age.<\/p>\n<p class=\"bwalignl\">At the heart of its clinically tested product portfolio is Niagen<sup>\u00ae<\/sup> (patented nicotinamide riboside, or NR), the most efficient, well-researched, and high-quality NAD+ booster available. Niagen powers the Company\u2019s consumer supplement, Tru Niagen<sup>\u00ae<\/sup>, the number one NAD+ boosting oral supplement in the United States\u2020 (available at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.truniagen.com&amp;esheet=54594900&amp;newsitemid=20260826608934&amp;lan=en-US&amp;anchor=www.truniagen.com&amp;index=4&amp;md5=aa238dc5b21a7ef3a1de818d6ff08f1c\">www.truniagen.com<\/a>), and Niagen\u2122 Plus, featuring pharmaceutical-grade intravenous (IV) and injectable Niagen products (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.niagenplus.com&amp;esheet=54594900&amp;newsitemid=20260826608934&amp;lan=en-US&amp;anchor=www.niagenplus.com&amp;index=5&amp;md5=37f90119430eb093d931695aa29b6a99\">www.niagenplus.com<\/a>). Pharmaceutical-grade Niagen IV and injections are compounded and distributed by U.S. FDA-registered 503B outsourcing facilities and are available exclusively at clinics with a prescription. NAD Pharmaceuticals Corp., the Company\u2019s wholly owned subsidiary focused on developing therapies for accelerated aging and rare genetic diseases, is conducting research on NB4168, a differentiated small molecule.<\/p>\n<p class=\"bwalignl\">Niagen Bioscience\u2019s robust patent portfolio protects NR and other NAD+ precursors. Niagen Bioscience maintains a website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.niagenbioscience.com&amp;esheet=54594900&amp;newsitemid=20260826608934&amp;lan=en-US&amp;anchor=www.niagenbioscience.com&amp;index=6&amp;md5=7d72dd7b63f08d6f05de7da09dfbd79c\">www.niagenbioscience.com<\/a>, where copies of press releases, news, and financial information are regularly published.<\/p>\n<p class=\"bwalignl\"><sup>\u2020<\/sup><i>Based on revenue per largest U.S. e-commerce marketplace (Jan. 2025 \u2013 Dec. 2025)<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260826608934\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260826608934\/en\/<\/a><\/span><\/p>\n<p class=\"bwalignl\"><b>Niagen Bioscience Media Contact:<\/b><br \/>Kendall Knysch, Senior Director of Media Relations &amp; Partnerships<br \/>310.405.5227<br \/><a rel=\"nofollow\" href=\"mailto:kendall.knysch@niagenbio.com\">kendall.knysch@niagenbio.com<\/a><\/p>\n<p class=\"bwalignl\"><b>Niagen Bioscience Investor Relations Contact:<\/b><br \/>Valter Pinto, Managing Director<br \/>KCSA Strategic Communications<br \/>212.896.1254<br \/><a rel=\"nofollow\" href=\"mailto:Niagen@kcsa.com\">Niagen@kcsa.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Science Pharmaceutical Research<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260826608934\/en\/2414362\/3\/Niagen_Bioscience_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate in the Nasdaq X LD Micro Inaugural SF Summit on Wednesday, September 9, 2026, in San Francisco, CA. Nasdaq is partnering with LD Micro to host 25 curated public companies, each delivering a 15-minute presentation to a room of institutional investors within the Nasdaq San Francisco office. Each presenting company will also participate in dedicated 15-minute breakout sessions immediately following their presentations, allowing interested investors to ask questions and engage directly with management. Niagen Bioscience CFO, Ozan &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-998196","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate in the Nasdaq X LD Micro Inaugural SF Summit on Wednesday, September 9, 2026, in San Francisco, CA. Nasdaq is partnering with LD Micro to host 25 curated public companies, each delivering a 15-minute presentation to a room of institutional investors within the Nasdaq San Francisco office. Each presenting company will also participate in dedicated 15-minute breakout sessions immediately following their presentations, allowing interested investors to ask questions and engage directly with management. Niagen Bioscience CFO, Ozan &hellip; Continue reading &quot;Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-26T12:36:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit\",\"datePublished\":\"2026-08-26T12:36:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/\"},\"wordCount\":562,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/\",\"name\":\"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-08-26T12:36:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/","og_locale":"en_US","og_type":"article","og_title":"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit - Market Newsdesk","og_description":"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate in the Nasdaq X LD Micro Inaugural SF Summit on Wednesday, September 9, 2026, in San Francisco, CA. Nasdaq is partnering with LD Micro to host 25 curated public companies, each delivering a 15-minute presentation to a room of institutional investors within the Nasdaq San Francisco office. Each presenting company will also participate in dedicated 15-minute breakout sessions immediately following their presentations, allowing interested investors to ask questions and engage directly with management. Niagen Bioscience CFO, Ozan &hellip; Continue reading \"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-26T12:36:01+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit","datePublished":"2026-08-26T12:36:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/"},"wordCount":562,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/","name":"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-08-26T12:36:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260826608934r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/niagen-bioscience-to-present-at-nasdaq-x-ld-micro-inaugural-sf-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=998196"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998196\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=998196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=998196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=998196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}